Ritalin Capsule, Extended Release
Product Images NDC 0078-0372

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ritalin (NDC 0078-0372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ritalin La Structural Formula. (Ritalin La 01)

Chemical structure of methylphenidate hydrochloride showing its molecular configuration, including a phenyl ring, ester group, and piperidine ring associated with the hydrochloride moiety.*

FDA Label Image

Figure 1: Mean Plasma Concentration Time-profile Of Methylphenidate After A Single Dose Of Ritalin La 40 mg And Ritalin 20 mg Given In Two Doses 4 Hours Apart) (Ritalin La 02)

A pharmacokinetic line graph comparing mean d-methylphenidate plasma levels (ng/mL) over time (hours) between Ritalin LA 40 mg once daily and Ritalin 20 mg twice daily groups. The graph shows plasma concentration trends for these two dosing regimens up to 24 hours.*

FDA Label Image

Figure 2: Kaplan-meier Investigator-determined Progression-free Survival Curves (Ritalin La 03)

A bar chart comparing mean final score minus mean baseline score between Ritalin LA (n=63) and placebo (n=71) groups. The Ritalin LA group shows a negative mean change around -10.7 with error bars representing standard error, while the placebo group shows a positive mean change around 1.27. The chart includes notes on sample sizes and error bars for standard error.*

FDA Label Image

Principal Display Panel Ndc 0078-0424-05 Rx Only Ritalin La® (methylphenidate HCl) Extended-release Capsules 10 mg 100 Tablets Dispense With Medication Guide Attached Or Provided Separately. Novartis (Ritalin La 04)

Ritalin LA 10 mg extended-release capsules label showing dosage strength, quantity of 100 capsules, and directions to dispense with Medication Guide. Manufactured for Novartis Pharmaceuticals Corporation with storage instructions and NDC 0078-0424-05. Label indicates prescription use only.*

FDA Label Image

Principal Display Panel Ndc 0078-0370-05 Rx Only Ritalin La® (methylphenidate HCl) Extended-release Capsules 20 mg 100 Tablets Dispense With Medication Guide Attached Or Provided Separately. Novartis (Ritalin La 05)

Label for Ritalin LA 20 mg extended-release capsules containing methylphenidate hydrochloride. The label shows the product name, strength, dosage form, quantity (100 capsules), and a notice for dispensing with a Medication Guide. It includes storage instructions, manufacturer details for Novartis Pharmaceuticals Corporation, and a barcode with the NDC 0078-0370-05.*

FDA Label Image

Principal Display Panel Ndc 0078-0371-05 Rx Only Ritalin La® (methylphenidate HCl) Extended-release Capsules 30 mg 100 Tablets Dispense With Medication Guide Attached Or Provided Separately. Novartis (Ritalin La 06)

Label for Ritalin LA 30 mg extended-release capsules (methylphenidate HCl) by Novartis Pharmaceuticals Corporation. The label shows 100 capsules with instructions to dispense with a medication guide. Storage conditions and manufacturer information are also provided.*

FDA Label Image

Principal Display Panel Ndc 0078-0372-05 Rx Only Ritalin La® (methylphenidate HCl) Extended-release Capsules 40 mg 100 Tablets Dispense With Medication Guide Attached Or Provided Separately. Novartis (Ritalin La 07)

Label for Ritalin LA 40 mg extended-release capsules (methylphenidate HCl) by Novartis Pharmaceuticals Corporation. The package contains 100 capsules. Includes storage instructions and a note to dispense with the Medication Guide. The label shows NDC 0078-0372-05 and indicates prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.